Form 4 for NOC Northrop Grumman
Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-15 · accession 0001628280-22-003041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-17 | 2022-02-15 | NOC | Jones Thomas H | CVP, Pres Aeronautics Systems | M - OptEx | $0.00 | +1,514 | 4,839 | +46% | $0 |
| D | 2022-02-17 | 2022-02-15 | NOC | Jones Thomas H | CVP, Pres Aeronautics Systems | F - Tax | $384.77 | -524 | 4,315 | -11% | -$201.6K |
| D | 2022-02-17 | 2022-02-16 | NOC | Jones Thomas H | CVP, Pres Aeronautics Systems | S - Sale+OE | $384.99 | -118 | 4,197 | -3% | -$45.4K |
| DM | 2022-02-17 | 2022-02-15 | NOC | Jones Thomas H | CVP, Pres Aeronautics Systems | A - Grant | $0.00 | +8,394 | 6,100 | New | $0 |
| D | 2022-02-17 | 2022-02-15 | NOC | Jones Thomas H | CVP, Pres Aeronautics Systems | M - OptEx | $0.00 | -1,514 | 13.4K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-15 | M | A | 1,514 | $0.00 | 4,838.82 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-15 | F | D | 524 | $384.77 | 4,314.82 | D | — | — | |
| 3 | Common | Common Stock | 2022-02-16 | S | D | 118 | $384.99 | 4,196.82 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
| 4 | Derivative | Restricted Performance Stock Rights | 2022-02-15 | A | A | 5,937 | $0.00 | 14,956 | D | — · — to — | 5,937 Common Stock | (F4) The RPSRs acquired include (i) 556 vested RPSRs with respect to the measurement period ended 12/31/21 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/13/19 that resulted in settlement at 158% of the target award; and (ii) 5,381 unvested RPSRs granted under the LTISP on 2/15/22 with a measurement period ending on 12/31/24. A total of 1,514 shares were issued in settlement of the 2019 RPSRs with a measurement period that ended 12/31/21, and the target award amount of 958 RPSRs was previously reported in connection with the grant of the 2019 RPSRs. (F3) Each Restricted Stock Performance Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). |
| 5 | Derivative | Restricted Stock Rights | 2022-02-15 | A | A | 2,457 | $0.00 | 6,100 | D | — · — to — | 2,457 Common Stock | (F2) Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the Long-Term Incentive Stock Plan ("LTISP") on 2/15/22 and will vest on 2/18/25. |
| 6 | Derivative | Restricted Performance Stock Rights | 2022-02-15 | M | D | 1,514 | $0.00 | 13,442 | D | — · — to — | 1,514 Common Stock | (F3) Each Restricted Stock Performance Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). |